Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children under 15 years old who are sick and visiting selected health facilities, whether for an outpatient appointment or staying in hospital
- Children who belong to higher-risk groups, including those under 2 years old, children living with HIV, or children who are severely malnourished
- Children who have been identified as having been in close contact with someone who has TB, found either through community outreach or at a health facility
- Children who show possible signs of TB, meaning they have had any one of these symptoms for more than 2 weeks without improvement: cough, fever, poor appetite, weight loss or poor growth, tiredness, reduced playfulness, or lower activity levels
- Children with severe malnutrition (SAM) are identified using standard measurements such as weight compared to height, arm circumference, or visible swelling in both legs (confirm with trial site for exact measurements used locally)
Who may not be able to join:
- There are no exclusion criteria for this trial — all eligible children will be offered the intervention
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Olivier Marcy, University of Bordeaux
Phone: +330557574723
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effectiveness endpoints: Children initiated on TB treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.